22 results
8-K
EX-1.1
BDTX
Black Diamond Therapeutics Inc
30 Jun 23
Entry into a Material Definitive Agreement
4:03pm
or enforced by the U.S. government, (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC … ”) or the U.S. Department of State and including, without limitation, the designation as a “specially designated national” or “blocked person”), the United
S-3
BDTX
Black Diamond Therapeutics Inc
14 Nov 22
Shelf registration
4:15pm
are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. Changes
S-3ASR
EX-1.2
znntlsu
1 Feb 21
Automatic shelf registration
5:28pm
S-3ASR
zrfb9gd
1 Feb 21
Automatic shelf registration
5:28pm
10-Q
s7ifvx87ug6
12 May 20
Quarterly report
7:34am
10-K
caqeq130dcaf4w r4az0
24 Mar 20
Annual report
7:47am
424B4
chzyu
30 Jan 20
Prospectus supplement with pricing info
4:43pm
S-1/A
7ce89d 5xhw8rv6mj7
21 Jan 20
IPO registration (amended)
8:24am
S-1/A
EX-1.1
97j70x qunku
21 Jan 20
IPO registration (amended)
8:24am
S-1
EX-10.11
dix4cp3 rmyl
3 Jan 20
IPO registration
3:23pm
S-1
7itxwdsc
3 Jan 20
IPO registration
3:23pm
DRS/A
m4wobdzi0s
13 Dec 19
Draft registration statement (amended)
12:00am
DRS/A
59gpcjn4a4a
30 Oct 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.11
yzf8no8h
7 Oct 19
Draft registration statement (amended)
12:00am